Radiopharmaceutical
Ga-68-DOTATATE vs. Ga-68-DOTATOC PET Scans for Meningioma
Recruiting1 awardPhase 2
New York, New York
This trial is evaluating different imaging scans to determine which one is more effective in detecting brain tumors in patients with meningioma. The scans use substances that make the tumors more visible, aiding doctors in their diagnosis.
Radioisotope Therapy
Lutathera for Meningioma
Recruiting1 awardPhase 2
New York, New York
This trial tests Lutathera, a targeted radiation therapy given through an IV, in patients with certain types of growing or high-risk brain tumors. The treatment aims to destroy tumor cells using targeted radiation.
Monoclonal Antibodies
Stereotactic Radiosurgery + Immunotherapy for Meningioma
Recruiting1 awardPhase 2
San Francisco, California
This trial is testing if a single dose of radiation therapy, given with the help of special equipment to target the tumor precisely, and a laboratory-made protein that blocks the PD-1 receptor, may improve progression-free survival for patients with meningioma that has come back.
Radioactive Drug
Lutathera for Progressive Meningioma
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial studies how well Lutathera works in treating patients with meningioma that cannot be treated with surgery and is getting worse after radiation therapy. Lutathera is a radioactive drug that targets and kills tumor cells. The goal is to see if it is safe and effective for these patients.
Checkpoint Inhibitor
Nivolumab + Radiosurgery for Recurrent Meningioma
Recruiting1 awardPhase 1 & 2
Phoenix, Arizona
This trial studies how well nivolumab and stereotactic radiosurgery, with or without ipilimumab, work in treating patients whose grade II-III meningioma has returned. The treatment aims to boost the immune system to fight cancer and use precise radiation to shrink the tumor. Nivolumab and ipilimumab are immune checkpoint inhibitors that have shown promise in treating various cancers, including brain metastases from melanoma.
Checkpoint Inhibitor
Nivolumab for Brain Cancer
Recruiting1 awardPhase 2
La Jolla, California
This trial will test whether the immunotherapy drug nivolumab is an effective treatment for people with rare CNS tumors by measuring the shrinkage of tumors or the amount of time it takes for the tumors to grow or spread.
Popular Filters
Trials for Brain Tumor Patients
Radioisotope Therapy
Lutathera for Brain Tumor
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial tests Lutathera, a radioactive drug given through an IV, in patients with certain brain tumors that haven't responded to other treatments. The drug attaches to cancer cells and uses radiation to kill them.
Radiation
Stereotactic Radiosurgery for Meningioma
Recruiting1 award4 criteria
San Francisco, California
This trial tests a type of radiation therapy called hypofractionated stereotactic radiosurgery for patients with grade II or recurrent grade I meningiomas. This treatment delivers high doses of radiation in a
Behavioural Intervention
Cognitive Behavioral Therapy for Insomnia in Brain Tumor Patients
Recruiting1 awardPhase 2
Richmond, Virginia
This trial aims to study a type of therapy called Cognitive Behavioral Therapy for Insomnia (CBT-I) in individuals with primary brain tumors who also have insomnia. The study will look at how feasible it
Trials for Diffuse Intrinsic Pontine Glioma Patients
Radioisotope Therapy
Lutathera for Brain Tumor
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial tests Lutathera, a radioactive drug given through an IV, in patients with certain brain tumors that haven't responded to other treatments. The drug attaches to cancer cells and uses radiation to kill them.
Trials for Metastatic Patients
CDK4/6 Inhibitor
Abemaciclib for Brain Cancer
Recruiting1 awardPhase 2
Hartford, Connecticut
This trial is testing a drug called abemaciclib in patients whose brain tumors have come back after treatment. The drug aims to stop the growth of cancer cells by blocking certain proteins that help them multiply. Researchers want to see both the positive and negative effects of this treatment. Abemaciclib is used primarily for treating metastatic breast cancer.
Trials With No Placebo
Radioisotope Therapy
Lutathera for Brain Tumor
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial tests Lutathera, a radioactive drug given through an IV, in patients with certain brain tumors that haven't responded to other treatments. The drug attaches to cancer cells and uses radiation to kill them.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.